NASDAQ · Biotechnology
MPLT (MPLT) Stock
$12.17
-8.36%
NASDAQ: MPLT
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Sector Update: Healthcare Stocks Rise Late Afternoon
MT Newswires · Jul 21, 2026
Sector Update: Healthcare
MT Newswires · Jul 21, 2026
MapLight Therapeutics Seen Having Upside in Schizophrenia Trial Readout, UBS Says
MT Newswires · Jul 21, 2026
Daily – Vickers Top Buyers & Sellers for 07/21/2026
Argus Research · Jul 21, 2026
Shopify downgraded, Five Below upgraded: Wall Street's top analyst calls
The Fly · Jul 21, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held51.69%
Institutions Held56.98%
Institutions Float Held117.94%
Peer Comparison
About MPLT
MPLT is led by CEO Christopher A. Kroeger, employs 109 people, headquartered in US, publicly traded since 2025.
MPLT stock trades at $12.17 with a market capitalization of $516.45M. The stock is valued at a price-to-earnings (P/E) ratio of -7.85, price-to-book of 0.05, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $9.90 and $39.80, and currently trades 69.4% below its 52-week high.
On profitability, MPLT generates a return on equity (ROE) of -35.15%, return on capital employed of -36.82%, an operating margin of 0.00%, a net profit margin of 0.00%.